Adjunctive simvastatin for treatment-resistant depression: study protocol of a 12-week randomised controlled trial

BACKGROUND: A third of patients diagnosed with major depressive disorder (MDD) experience treatment-resistant depression (TRD). Relatively few pharmacological agents have established efficacy for TRD. Therefore, the evaluation of novel treatments for TRD is a pressing priority. Statins are pleiotrop...

Descripción completa

Detalles Bibliográficos
Autores principales: Husain, Muhammad I., Chaudhry, Imran B., Khoso, Ameer B., Husain, Mohammad Omair, Rahman, Raza R., Hamirani, Munir M., Hodsoll, John, Carvalho, Andre F., Husain, Nusrat, Young, Allan H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2019
Materias:
Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6381416/
https://www.ncbi.nlm.nih.gov/pubmed/30762508
http://dx.doi.org/10.1192/bjo.2018.84

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6381416/
https://www.ncbi.nlm.nih.gov/pubmed/30762508
http://dx.doi.org/10.1192/bjo.2018.84

Ejemplares similares